| Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 MG Ott, M Schmidt, K Schwarzwaelder, S Stein, U Siler, U Koehl, H Glimm, ... Nature medicine 12 (4), 401-409, 2006 | 1370 | 2006 |
| Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease S Stein, MG Ott, S Schultze-Strasser, A Jauch, B Burwinkel, A Kinner, ... Nature medicine 16 (2), 198-204, 2010 | 900 | 2010 |
| New insights to the MLL recombinome of acute leukemias C Meyer, E Kowarz, J Hofmann, A Renneville, J Zuna, J Trka, ... Leukemia 23 (8), 1490-1499, 2009 | 515 | 2009 |
| Treatment of patients with advanced cancer with the natural killer cell line NK-92 T Tonn, D Schwabe, HG Klingemann, S Becker, R Esser, U Koehl, ... Cytotherapy 15 (12), 1563-1570, 2013 | 476 | 2013 |
| Cochlear implant–state of the art T Lenarz Laryngo-rhino-otologie 96 (S 01), S123-S151, 2017 | 344 | 2017 |
| Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor K Schönfeld, C Sahm, C Zhang, S Naundorf, C Brendel, M Odendahl, ... Molecular therapy 23 (2), 330-338, 2015 | 334 | 2015 |
| The MLL recombinome of acute leukemias C Meyer, B Schneider, S Jakob, S Strehl, A Attarbaschi, S Schnittger, ... Leukemia 20 (5), 777-784, 2006 | 279 | 2006 |
| Advantages and applications of CAR-expressing natural killer cells W Glienke, R Esser, C Priesner, JD Suerth, A Schambach, WS Wels, ... Frontiers in pharmacology 6, 21, 2015 | 270 | 2015 |
| Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow … I Yakoub-Agha, C Chabannon, P Bader, GW Basak, H Bonig, F Ciceri, ... haematologica 105 (2), 297, 2020 | 267 | 2020 |
| 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model W Brenner, A Aicher, T Eckey, S Massoudi, M Zuhayra, U Koehl, ... Journal of Nuclear Medicine 45 (3), 512-518, 2004 | 264 | 2004 |
| Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy K Sasaki, C Heeschen, A Aicher, T Ziebart, J Honold, C Urbich, L Rossig, ... Proceedings of the National Academy of Sciences 103 (39), 14537-14541, 2006 | 262 | 2006 |
| Targeted cell entry of lentiviral vectors S Funke, A Maisner, MD Mühlebach, U Koehl, M Grez, R Cattaneo, ... Molecular Therapy 16 (8), 1427-1436, 2008 | 259 | 2008 |
| CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties S Kuçi, Z Kuçi, H Kreyenberg, E Deak, K Pütsch, S Huenecke, C Amara, ... haematologica 95 (4), 651, 2010 | 216 | 2010 |
| NK cells engineered to express a GD2‐specific antigen receptor display built‐in ADCC‐like activity against tumour cells of neuroectodermal origin R Esser, T Müller, D Stefes, S Kloess, D Seidel, SD Gillies, ... Journal of cellular and molecular medicine 16 (3), 569-581, 2012 | 198 | 2012 |
| Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the … PJ Hayden, C Roddie, P Bader, GW Basak, H Bonig, C Bonini, ... Annals of Oncology 33 (3), 259-275, 2022 | 195 | 2022 |
| Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers M Stern, JR Passweg, S Meyer-Monard, R Esser, T Tonn, J Soerensen, ... Bone marrow transplantation 48 (3), 433-438, 2013 | 188 | 2013 |
| Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors B Anliker, T Abel, S Kneissl, J Hlavaty, A Caputi, J Brynza, IC Schneider, ... Nature methods 7 (11), 929-935, 2010 | 184 | 2010 |
| IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation U Koehl, J Sörensen, R Esser, S Zimmermann, HP Grüttner, T Tonn, ... Blood Cells, Molecules, and Diseases 33 (3), 261-266, 2004 | 177 | 2004 |
| Shaping of natural killer cell antitumor activity by ex vivo cultivation M Granzin, J Wagner, U Köhl, A Cerwenka, V Huppert, E Ullrich Frontiers in immunology 8, 257309, 2017 | 163 | 2017 |
| Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus O Beck, MS Topp, U Koehl, E Roilides, M Simitsopoulou, M Hanisch, ... Blood 107 (6), 2562-2569, 2006 | 150 | 2006 |
